Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / CL A
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
15,947,499
-
Shares change
-
+213,087
-
Total reported value, excl. options
-
$894,554,113
-
Value change
-
+$8,402,296
-
Put/Call ratio
-
120%
-
Number of buys
-
75
-
Number of sells
-
-43
-
Price
-
$56.1
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2018
149 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q4 2018.
REATA PHARMACEUTICALS INC - CL A (RETA) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,947,499 shares
.
Largest 10 shareholders include CPMG Inc (3,023,349 shares), BlackRock Inc. (1,958,164 shares), Vanguard Group Inc (1,258,234 shares), FRANKLIN RESOURCES INC (961,299 shares), FARALLON CAPITAL MANAGEMENT LLC (700,000 shares), Cormorant Asset Management, LP (674,251 shares), EMERALD MUTUAL FUND ADVISERS TRUST (486,210 shares), EMERALD ADVISERS, LLC (470,431 shares), STATE STREET CORP (445,120 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (397,935 shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.